SAFC and BioReliance had a busy week across the globe as a handful of announcements went live offering a look into expanding product lines and facilities, newly acquired licenses and a promotion to President of SAFC.
SAFC Expands the Irvine, Scotland facility to include dry powder media capability and offer redundancy with Lenexa facility. Click here for the full release.
The PharmaGrade line grows to 80 products, with plans to double by end of 2013. Click here for the full release.
Archie Cullen named President of BioReliance, with an official start date of April 1, 2013. Click here for the full release.
BioReliance acquires the colonies required for the Big Blue® transgenic rodent mutation (TRM) assay. Click here for the full release.